| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.94.6.1216 |
| P698 | PubMed publication ID | 8822972 |
| P2093 | author name string | Wang S | |
| Hokanson JE | |||
| Chait A | |||
| Alpers CE | |||
| O'Brien KD | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 1216-1225 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein | |
| P478 | volume | 94 |
| Q43737731 | Alpha-tocopherol and probucol reduce autoantibody titer to MDA-LDL in hypercholesterolemic rabbits |
| Q35172086 | Autoantibody-mediated atherosclerosis |
| Q47910728 | Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation |
| Q33610725 | Can antioxidant vitamins materially reduce oxidative damage in humans? |
| Q30664287 | Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification. |
| Q36362707 | Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease |
| Q41137063 | Coronary heart disease: Significance of liver X receptor α genomics |
| Q33993678 | Current, new and future treatments in dyslipidaemia and atherosclerosis |
| Q34106538 | Histochemical visualization of oxidant stress |
| Q58230333 | Immune system activation follows inflammation in unstable angina: pathogenetic implications |
| Q44016819 | Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice |
| Q78125646 | Intracellular generation of MDA-LYS epitope in foam cells |
| Q73835683 | Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway |
| Q44069283 | Localization of oxidation-specific epitopes in tissue |
| Q37091275 | Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. |
| Q40851209 | Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein |
| Q36834626 | Management of pulmonary hypertension in the operating room |
| Q49422978 | NADPH Oxidase Deficiency: A Multisystem Approach |
| Q77601534 | Oxidized phospholipids as a new landmark in atherosclerosis |
| Q43833271 | Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E. |
| Q34310277 | Pathophysiology of oxidative stress in diabetes mellitus |
| Q44249438 | Patterns of oxidized epitopes, but not NF-kappa B expression, change during atherogenesis in WHHL rabbits |
| Q24322032 | Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women |
| Q46442680 | Pravastatin attenuates the action of the ETS domain-containing protein ELK1 to prevent atherosclerosis in apolipoprotein E-knockout mice via modulation of extracellular signal-regulated kinase 1/2 signal pathway |
| Q79402060 | Relation between plasma oxLDL antibodies and oxLDL in the circulation |
| Q28210092 | Relationship between endothelial dysfunction, oxidant stress and aspirin resistance in patients with stable coronary heart disease |
| Q73406735 | The distribution of oxidatively-modified lysine in the human vasculature |
| Q34006328 | The oxidative modification hypothesis of atherogenesis: an overview |
Search more.